[NBY] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
10-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -131.86%
YoY- -87.10%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 2,631 3,727 3,255 4,610 3,124 3,643 3,826 -22.07%
PBT -3,090 -4,108 -1,757 -2,036 -1,739 -8,206 -136 700.67%
Tax 124 302 -51 -256 5 -3,488 -321 -
NP -3,214 -4,108 -1,757 -4,032 -1,739 -8,206 -5,793 -32.45%
Tax Rate - - - - - - - -
Total Cost 5,845 7,835 5,012 8,642 4,863 11,849 9,619 -28.23%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -122.16 -110.22 -53.98 -87.46 -55.67 -225.25 -151.41 -13.32%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -4.92 -46.53 -13.11 -40.92 -23.13 -151.72 -126.40 -88.49%
EPS Diluted -4.92 -46.53 -13.11 -40.92 -23.13 -151.72 -126.40 -88.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.